CClinicalTrials.gg
TerminatedNCT01911793Updated Mar 7, 2018Results posted

Stoma Tube Decompression and Postoperative Ileus After Major Colorectal Surgery

An interventional study of Stoma Tube in Ileus and Bowel Obstruction, sponsored by Cedars-Sinai Medical Center. Terminated at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-03-07.

Sponsored by Cedars-Sinai Medical Center · Not applicable, Interventional, and Prevention

Why this study was terminated
Not enough staff resource to complete study.
Phase
Not applicable
Study type
Interventional
Enrollment
6
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Postoperative ileus is common after colorectal surgery, occurring in up to 20% of patients. Stomas are frequently created in conjunction with major colorectal surgery. Obstruction at the level of the stoma is a common cause of bowel obstruction or ileus. This is often manifested by decrease or delay in stoma output and is often attributed to edema at the level of the stoma. Thus, a temporary tube (red robinson catheter) is placed into the stoma at bedside, which often relieves the obstruction until the edema at the level of the stoma resolves and stoma function occurs around the temporary tube. At this time, the tube is removed and the stoma continues to function normally.

The purpose of this study is to evaluate whether a stoma tube (red-robinson catheter) placed at the time of stoma creation would reduce the incidence of postoperative ileus in patients undergoing major colorectal surgery with creation of a stoma.

02

Conditions studied

  • Ileus
  • Bowel Obstruction

Keywords

  • stoma
  • ileus
  • postoperative
  • stoma tube
03

In context

Ileus

124 studies on the registry are indexed under Ileus; 12 are open to participants now.

This study's enrollment of 6 is below the median of 97 across 106 interventional studies indexed under Ileus.

Browse Ileus studies →

Lead sponsor

Cedars-Sinai Medical Center is the lead sponsor of 442 studies on the registry; 109 are open to participants now.

Of its 62 completed or terminated interventional studies of FDA-regulated products, 47 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Able to freely give written informed consent to participate in the study and have signed the Informed Consent Form;
  2. Males or females, 18> years of age and older inclusive at the time of study screening;
  3. American Society of Anesthesiologists (ASA) Class I-III (Appendix III);
  4. Due to undergo ileostomy or colostomy creation via laparotomy or laparoscopy;

Exclusion criteria

Exclusion Criteria:

  1. Mentally incompetent or unable or unwilling to provide informed consent or comply with study procedures;
  2. American Society of Anesthesiologists (ASA) Class IV or V;
  3. Children \<18 years
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
6 participants (actual)

Study arms

  • Experimental
    Stoma tube

    Stoma tube (18 French) red robinson catheter inserted into stoma at the time of surgery

    Device: Stoma Tube

  • No intervention
    Standard Stoma

    Patients will have standard stoma created without insertion of stoma tube. Stoma tube will only be inserted postoperative if the patient is felt to have postoperative ileus, nausea, vomiting, and decreased stoma output as per standard protocol.

Interventions

  • DeviceStoma Tube

    Stoma tube will be inserted into stoma at the time of surgery for patients assigned to Stoma Tube group.

    Also known as: Red robinson catheter

06

What researchers measure

Primary outcomes

  1. Tolerating Low Residue Diet

    % of patients tolerating a low residue diet on postoperative day 3 will be assessed

    Time frame: by postoperative day 3( 3rd day after surgery)

Secondary outcomes

  1. Time to Flatus (Passing Gas Into Stoma Bag)

    # of hours after surgery at which point first passage of flatus (gas) into stoma bag

    Time frame: during 30 day postoperative period

  2. Time to Passage of Stool

    # of hours after surgery until the patient passes stool into stoma bag

    Time frame: during 30 day postoperative period

  3. Hospital Discharge

    postoperative day after surgery which patient was discharged home

    Time frame: 30 day postoperative period

  4. Time to Discharge Based on GI Function

    postoperative day which patient is considered ready for discharge based solely on Gastrointestinal function

    Time frame: 30 day postoperative period

  5. Major and Minor Medical and Surgical Complications

    any major or minor medical and surgical complications after surgery will be recorded

    Time frame: 30 day postoperative period

  6. Any Insertion of Nasogastric Tube

    insertion of nasogastric tube after surgery will be recorded

    Time frame: 30 day postoperative period

  7. Episodes of Vomiting

    any episodes of vomiting will be recorded

    Time frame: during postoperative hospital admission (30 day period)

  8. Diagnosis of Postoperative Ileus

    diagnosis of postoperative ileus or bowel obstruction made by attending surgeon based on clinical data including abdominal distention, nausea/vomiting, decreased stom output and radiologic factors

    Time frame: 30 day postoperative period

07

Results

Posted Jun 28, 2017
Limitations and caveats
Study only accrued 6 patients. Due to poor enrollment and issues with administrative coverage for study it was decided to terminate the study. NO data analysis has been done and will not be done in the future. This study was closed with the IRB.

Participant flow

Participant flow — Overall Study
MilestoneStoma TubeStandard Stoma
Started15
Completed00
Not completed15
Withdrew: Physician decision15

Outcome measures

PrimaryTolerating Low Residue Diet

% of patients tolerating a low residue diet on postoperative day 3 will be assessed

Time frame:
by postoperative day 3( 3rd day after surgery)

No measurements were reported for this outcome.

SecondaryTime to Flatus (Passing Gas Into Stoma Bag)

# of hours after surgery at which point first passage of flatus (gas) into stoma bag

Time frame:
during 30 day postoperative period

No measurements were reported for this outcome.

SecondaryTime to Passage of Stool

# of hours after surgery until the patient passes stool into stoma bag

Time frame:
during 30 day postoperative period

No measurements were reported for this outcome.

SecondaryHospital Discharge

postoperative day after surgery which patient was discharged home

Time frame:
30 day postoperative period

No measurements were reported for this outcome.

SecondaryTime to Discharge Based on GI Function

postoperative day which patient is considered ready for discharge based solely on Gastrointestinal function

Time frame:
30 day postoperative period

No measurements were reported for this outcome.

SecondaryMajor and Minor Medical and Surgical Complications

any major or minor medical and surgical complications after surgery will be recorded

Time frame:
30 day postoperative period

No measurements were reported for this outcome.

SecondaryAny Insertion of Nasogastric Tube

insertion of nasogastric tube after surgery will be recorded

Time frame:
30 day postoperative period

No measurements were reported for this outcome.

SecondaryEpisodes of Vomiting

any episodes of vomiting will be recorded

Time frame:
during postoperative hospital admission (30 day period)

No measurements were reported for this outcome.

SecondaryDiagnosis of Postoperative Ileus

diagnosis of postoperative ileus or bowel obstruction made by attending surgeon based on clinical data including abdominal distention, nausea/vomiting, decreased stom output and radiologic factors

Time frame:
30 day postoperative period

No measurements were reported for this outcome.

Adverse events

Collected over Data were not collected and no data was analyzed study was terminated due to issues with study enrollment and study administrative coverage. Total Number of Participants at Risk (e.g., "All-Cause Mortality, Serious, and Other [Not Including Serious] Adverse Events were not monitored/assessed for this study.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Stoma Tube———
Standard Stoma———

Baseline characteristics

Data were not collected and no data was analyzed study was terminated due to issues with study enrollment and study administrative coverage.

Age, Categorical
Age, CategoricalStoma TubeStandard StomaTotal
<=18 years———
Between 18 and 65 years———
>=65 years———
Age, Continuous
Age, ContinuousStoma TubeStandard StomaTotal
Sex: Female, Male
Sex: Female, MaleStoma TubeStandard StomaTotal
Female———
Male———
Region of Enrollment
Region of Enrollment(participants)Stoma TubeStandard StomaTotal
08

Study locations

1 site
  • Cedars Sinai Medical Center
    Los Angeles, California 90048, United States
09

References and documents

Publications

  • Iyer S, Saunders WB, Stemkowski S. Economic burden of postoperative ileus associated with colectomy in the United States. J Manag Care Pharm. 2009 Jul-Aug;15(6):485-94. doi: 10.18553/jmcp.2009.15.6.485. PubMed 19610681 ↗
  • Akesson O, Syk I, Lindmark G, Buchwald P. Morbidity related to defunctioning loop ileostomy in low anterior resection. Int J Colorectal Dis. 2012 Dec;27(12):1619-23. doi: 10.1007/s00384-012-1490-y. Epub 2012 May 11. PubMed 22576906 ↗
  • Le Q, Liou DZ, Murrell Z, Fleshner P. Does a history of postoperative ileus predispose to recurrent ileus after multistage ileal pouch-anal anastomosis? Tech Coloproctol. 2013 Aug;17(4):383-8. doi: 10.1007/s10151-012-0942-2. Epub 2012 Nov 27. PubMed 23183687 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 7, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01911793
Lead sponsor
Cedars-Sinai Medical Center
Responsible party
Phillip Fleshner MD (Director of Colorectal Surgery Residency, Cedars-Sinai Medical Center) — Principal investigator
First posted
Jul 30, 2013
Start date
Jul 2013
Primary completion
Jul 2014
Completion
Jul 2014
Results posted
Jun 28, 2017
Last update
Mar 7, 2018

Study contacts

Phillip Fleshner, MD
principal investigator · Cedars-Sinai Medical Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion